Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2005-10-27
2010-06-01
Mondesi, Robert (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S078030, C424S282100, C530S412000
Reexamination Certificate
active
07727537
ABSTRACT:
A stabilizing composition that also enhances permeation is provided for the topical or transdermal administration of an active ingredient. The composition preferably comprises collagen, elastin, sphingoside and cerebroside. Also provided are pharmaceutical or cosmetic formulations comprising an effective amount of an active agent and the stabilizing composition as well as methods of administering active agents topically or transdermally.
REFERENCES:
patent: 5728391 (1998-03-01), Ikeya et al.
patent: 6585993 (2003-07-01), Donovan et al.
patent: 6638621 (2003-10-01), Anderson
patent: 6689349 (2004-02-01), Wohlrab et al.
patent: 6756045 (2004-06-01), Neudecker et al.
patent: 6806259 (2004-10-01), Udell et al.
patent: 6998113 (2006-02-01), Traynor et al.
patent: 2003/0118598 (2003-06-01), Hunt
patent: 2004/0033254 (2004-02-01), Song et al.
patent: 2004/0060569 (2004-04-01), Hanin
patent: 2004/0247623 (2004-12-01), Cady
patent: 198 05 827 A 1 (1999-08-01), None
patent: 0319638 (1989-06-01), None
patent: 0525167 (1995-09-01), None
patent: 0812186 (2001-10-01), None
patent: 1 475 099 (2004-11-01), None
patent: WO9101719 (1991-02-01), None
patent: WO 01/58472 (2001-08-01), None
patent: WO03015698 (2003-02-01), None
patent: WO 2004/060384 (2004-07-01), None
patent: WO2005046637 (2005-05-01), None
Carpender et al., Interactions of Stabilizing Additives with Proteins During Freeze-Thawing and Freeze-Drying, International Symposium on Biological Product Freeze-Drying and Formulation, Oct. 24-26, 1990; Krager (1992), 225-239.
Goodnough et al., Stabilization of Botulinum Toxin Type A During Lyophilization, App & Envir. Micro. 58 (10) 3426-3428 (1992).
Schmidt, et al., Endoproteinase Activity of Type A Botulinum Neurotoxin Substrate Requirements and Activation by Serum Albumin, J. of Protein Chemistry, 16(1), 19-26 (1997).
DPM Therapeutics Corp.
Fornari James D.
Gersten Savage LLP
Mondesi Robert
Shahnan-Shah Khatol
LandOfFree
Stabilized compositions for topical administration and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stabilized compositions for topical administration and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilized compositions for topical administration and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4174303